What impact have new minimal residual disease (MRD) assessment techniques had in myeloma?
Are combination therapies more effective for the treatment of relapsed refractory CLL?
Myeloma 2016: Panel discussion on novel treatments
Keith Stewart et al.
Relapsed follicular lymphoma: hope from a non-chemotherapy regimen of lenalidomide and obinutuzumab
Reinforcing transplantation with consolidation therapy in Hodgkin lymphoma